Precision Biosciences (DTIL) Interest Coverage Ratio Growth (1y) (2020 - 2026)
Precision Biosciences (DTIL) Interest Coverage Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -347.04% |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 1,378.45% |
| 10 | Precision Biosciences | 182.42 Mn | 154.13 Mn | - | 60.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.19% |
| Dec 31, 2025 | 128.23% |
| Sep 30, 2025 | -20.77% |
| Jun 30, 2025 | -770.71% |
| Mar 31, 2025 | -526.31% |
| Dec 31, 2024 | -147.61% |
| Sep 30, 2024 | 94.86% |
| Jun 30, 2024 | 573.76% |
| Mar 31, 2024 | 68.76% |
| Dec 31, 2023 | -206.50% |
| Sep 30, 2023 | -50.04% |
| Jun 30, 2023 | 89.24% |
| Mar 31, 2023 | -503.49% |
| Dec 31, 2022 | 97.95% |
| Sep 30, 2022 | -2,453.64% |
| Jun 30, 2022 | -144.87% |
| Mar 31, 2022 | 86.27% |
| Dec 31, 2021 | -1,042.23% |
| Sep 30, 2021 | 88.12% |
| Jun 30, 2021 | 174.30% |